Comparison of Overall Function Between Postpartum Women With and Without Diastasis Rectus Abdominis

NCT ID: NCT05709704

Last Updated: 2023-02-02

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

150 participants

Study Classification

OBSERVATIONAL

Study Start Date

2021-07-02

Study Completion Date

2023-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this research is to examine the effects of diastasis rectus abdominis on the overall function of postpartum women and to determine test-retest reliability and construct validity of a self-assessment palpation of inter-rectus distance for DRA using telehealth.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Step 1: Recruitment

* The investigators will place recruitment fliers in local obstetrician offices, labor and delivery units in local hospitals, retail and daycare establishments, and on social media outlets such as Facebook, Instagram and Twitter.
* The recruitment fliers will ask interested women to email a student investigator to enroll in the research project.

Step 2: Collection of functional outcome data using a Qualtrics version of the Inventory of Functional Status After Childbirth (IFSAC), a demographic survey, a numeric pain reporting scale, Oswestry Low Back Pain Disability Questionnaire, and the Pelvic Floor Distress Index.

Step 3: A meeting time will be set up with every participant to conduct a telehealth visit with a research assistant. During this virtual visit on a private, password protected Zoom call the participant will be instructed on self-assessment palpation of the abdominal wall in order to determine the presence or absence of diastasis rectus abdominis (DRA) along the inter-rectus distance (IRD).

Step 4: The first 18 participants with self-assessed DRA and the first 18 participants without self-assessed DRA, who live in Wichita or surrounding areas, will be scheduled for a one-time in-person confirmation appointment. The appointment will last a maximum of 15 minutes and occur at the WSU Old Town campus room A106. During this confirmation appointment research assistants will screen the participant with the COVID Pre-screening Questions Tool, obtain written informed consent, check the participant in, collect height and weight, and the principal investigator will measure the participants abdominal wall using real-time ultrasound, measure the IRD using the PI's palpation method, and ask the participant to demonstrate and measure IRD using the same palpation method used on the telehealth visit. See the virus protection plan for details of which all participants and investigators will follow in order to minimize risks related to COVID-19).

Step 5: The data will be entered into SPSS and analyzed with appropriate statistical analyses.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Diastasis Recti

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Postpartum Women WITH DRA

Participants who have the diagnosis of diastasis rectus abdominis

Self-palpation via telehealth

Intervention Type DIAGNOSTIC_TEST

This will be used to determine if the participant has the diagnosis

Real-time Ultrasound

Intervention Type DIAGNOSTIC_TEST

This will be used in a subgroup of participants to confirm/rule out a diagnosis

Postpartum Women WITHOUT DRA

Participants who do not have a diagnosis of diastasis rectus abdominis

Self-palpation via telehealth

Intervention Type DIAGNOSTIC_TEST

This will be used to determine if the participant has the diagnosis

Real-time Ultrasound

Intervention Type DIAGNOSTIC_TEST

This will be used in a subgroup of participants to confirm/rule out a diagnosis

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Self-palpation via telehealth

This will be used to determine if the participant has the diagnosis

Intervention Type DIAGNOSTIC_TEST

Real-time Ultrasound

This will be used in a subgroup of participants to confirm/rule out a diagnosis

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Women ages 18-40 years
* Postpartum (within 6-10 weeks of vaginal delivery)

Exclusion Criteria

* Women who are currently being treated by a physical therapist for their diastasis rectus abdominis
* Women who had high-risk pregnancies (bedrest, gestational diabetes, pregnancy-induced hypertension)
* Women with a history of abdominal or back surgery
* Women with history of connective tissue disease such as Ehlers-Danlos Syndrome
Minimum Eligible Age

18 Years

Maximum Eligible Age

40 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Wichita State University

OTHER

Sponsor Role collaborator

Texas Woman's University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Wichita State University

Wichita, Kansas, United States

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United States

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Jennifer Celso, DPT

Role: primary

316-978-5648

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

IRB-FY2021-405

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Durometer for Measuring Uterine Tone
NCT06284421 RECRUITING NA